Trials / Unknown
UnknownNCT00004375
Ultraviolet Light Therapy for Systemic Lupus Erythematosus
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- National Center for Research Resources (NCRR) · NIH
- Sex
- All
- Age
- 15 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
OBJECTIVES: I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.
Detailed description
PROTOCOL OUTLINE: Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ultraviolet A-1 light treatment |
Timeline
- Start date
- 1991-09-01
- First posted
- 1999-10-19
- Last updated
- 2005-06-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00004375. Inclusion in this directory is not an endorsement.